Oncopeptides AB (OSTO:ONCO) Total Tax Payable : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB Total Tax Payable?

Oncopeptides AB's Total Tax Payable for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Oncopeptides AB's annual Total Tax Payable declined from Dec. 2022 (kr6.78 Mil) to Dec. 2023 (kr0.00 Mil) but then stayed the same from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr0.00 Mil).

Oncopeptides AB Total Tax Payable Historical Data

The historical data trend for Oncopeptides AB's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB Total Tax Payable Chart

Oncopeptides AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Tax Payable

Get a 7-Day Free Trial

14.24

7.03

6.78

Oncopeptides AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	-

Oncopeptides AB Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Oncopeptides AB Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (OSTO:ONCO) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

0RN4:UK OND:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, SE-111 53

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and in particular multiple myeloma.